[Form 4] Bunge Global SA Insider Trading Activity

Rhea-AI Filing Summary

Christos Dimopoulos, Executive VP, Global Markets at Bunge Global SA (BG), acquired 240 restricted stock units on 09/02/2025. The Form 4 shows the grant was recorded at a price of $82.44 and is described as restricted stock units issued pursuant to a dividend feature under the registrant's long-term incentive plans. Following the reported transaction, the filing lists 124,536.808 shares as the amount of common stock beneficially owned.

Positive

• Officer acquired 240 restricted stock units, increasing his reported beneficial ownership to 124,536.808 shares as disclosed on Form 4.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine executive equity grant reported; increases reported beneficial ownership but appears to be standard long-term incentive compensation.

The filing documents a non-derivative acquisition of 240 restricted stock units by an executive officer under the company’s long-term incentive plans, arising from a dividend feature. This is a common mechanism to deliver equity-based compensation and aligns the officer’s interests with shareholders. The report is administrative and compliance-focused, fulfilling Section 16 reporting requirements.

Compensation Analyst

TL;DR: Non-cash equity award recorded; materiality appears limited to compensation disclosure rather than operational impact.

The transaction reflects issuance of 240 RSUs at $82.44 and increases the reported beneficial ownership to 124,536.808 shares. The explanation indicates these RSUs were issued pursuant to a dividend feature of the registrant’s long-term incentive plans. There is no information here about vesting, service conditions, or aggregate value beyond the per-unit price shown.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dimopoulos Christos

(Last) (First) (Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD MO 63017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP, Global Markets

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		A		240(1)	A	$82.44	124,536.808	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units acquired on September 2, 2025 pursuant to a dividend feature under the registrant's long-term incentive plans.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christos Dimopoulos report on the Form 4 for BG?

The Form 4 reports the acquisition of 240 restricted stock units on 09/02/2025 described as issued under a dividend feature of the registrant's long-term incentive plans.

How many shares does the filing show Christos Dimopoulos beneficially owns after the transaction?

The filing lists 124,536.808 shares of common stock as beneficially owned following the reported transaction.

What price is shown on the Form 4 for the restricted stock units?

The Form 4 indicates a price of $82.44 associated with the reported acquisition.

Was this transaction a sale or an acquisition?

The transaction code in Table I is A, indicating an acquisition of securities (240 RSUs).

Does the filing explain the nature of the award?

Yes. The explanation states these are restricted stock units acquired pursuant to a dividend feature under the registrant's long-term incentive plans.